Otolaryngology · Indiana, PA
NPI
1790722171
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1265 Wayne Avenue, Suite 100
Indiana, PA, 15701
Phone (724) 349-5440
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,200 services
Medicare patients, 2024
543
Average age 75
Drug cost, 2024
$105K
4,187 prescriptions
Company payments, 2025
$13.9
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bosco E Noronha was code 99213 (office e&m - established), 786 times for 441 patients. In total Bosco E Noronha billed 1,200 services in 40 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 786 | 441 | $57.68 | $45K |
| 99203 Office E&M - New | Office | 150 | 150 | $71.49 | $11K |
| 31231 Nasal/Sinus Endoscopy | Office | 85 | 76 | $116.65 | $9,915 |
| 31575 Other Organ Systems | Office | 70 | 58 | $81.03 | $5,672 |
| 69420 Other Organ Systems | Office | 15 | 11 | $117.93 | $1,769 |
By year: 2022 $99K for 1,296 services; 2023 $89K for 1,217 services; 2024 $86K for 1,200 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bosco E Noronha prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 1,117 prescriptions and refills. In total Bosco E Noronha wrote 4,187 Medicare prescriptions that cost $105K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 1,117 | 2,770 | 335 | $28K |
| Famotidine Generic | 438 | 1,101 | 152 | $7,109 |
| Fluticasone Propionate Generic | 437 | 897 | 176 | $6,940 |
| Azelastine Hcl Generic | 305 | 689 | 105 | $8,736 |
| Montelukast Sodium Generic | 252 | 544 | 63 | $4,248 |
| Pantoprazole Sodium Generic | 244 | 648 | 91 | $3,492 |
| Ipratropium Bromide Generic | 223 | 471 | 108 | $11K |
| Prednisone Generic | 202 | 202 | 189 | $558 |
| Methylprednisolone Generic | 162 | 162 | 152 | $1,082 |
| Mometasone Furoate Generic | 106 | 210 | 52 | $8,157 |
| Fluocinolone Acetonide Oil Generic | 64 | 99 | 39 | $2,644 |
| Desloratadine Generic | 61 | 147 | 21 | $4,476 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 60 | 60 | 57 | $720 |
| Clonazepam Generic | 47 | 83 | 11 | $211 |
| Sucralfate Generic | 45 | 70 | 16 | $888 |
Brand drugs: 46 claims; generic drugs: 4,141 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bosco E Noronha $13.9 ($13.9 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $13.9.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $13.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.